ABSTRACT
Objective To investigate the metabolic pattern of different types of iron accumulation in multiple sclerosis(MS) lesions, and compare metabolic alterations within and at the periphery of lesions and newly emerging lesions in vivo according to iron deposition.
Methods 7T MR spectroscopic imaging and susceptibility-weighted-imaging was performed in 31 RRMS patients(16female/15male;mean age,36.9±10.3years). Mean metabolic ratio were calculated for regions of interest(ROI) of normal appearing white matter(NAWM), “non-iron”, and three distinct types of iron-laden lesions, and for lesion layers of “non-iron” and “rim” lesions. Furthermore, newly emerging “non-iron” and “iron” lesions were compared longitudinally.
Results 52% of iron-containing lesions showed no distinct paramagnetic rim. Of these, “area” lesions exhibited a 65% higher mIns/tNAA(p=0.035) than “rim” lesions. Comparing lesion layers of both “non-iron” and “rim” lesions, a steeper metabolic gradient of mIns/tNAA(“non-iron”+15%,”iron”+40%) and tNAA/tCr(“non-iron”-15%,”iron”-35%) was found in “iron” lesions, with the lesion core showing +22% higher mIns/tNAA(p=0.005) and -23% lower tNAA/tCr(p=0.048) in “iron” compared to “non-iron” lesions. In newly emerging lesions, 46% showed iron accumulation, with the drop in tNAA/tCr after lesion formation remaining significantly lower compared to pre-lesional tissue over time in “iron” lesions(year0:p=0.013,year1:p=0.041) as opposed to “non-iron” lesions(year0:p=0.022,year1:p=0.231).
Conclusion 7T MRSI allows in vivo characterization of different iron accumulation types showing metabolic differences. Furthermore, the larger extent of neuronal damage in lesions with a distinct iron rim was reconfirmed, but with metabolic differences in lesion development between (non)-iron-containing lesions. This highlights the ability of MRSI to further investigate different types of iron accumulation and suggests possible implications for disease monitoring.
Clinical relevance statement The clinical importance of differentiating various types of iron accumulation in MS lesions was shown, as contrasting metabolic profiles are likely associated with different levels of tissue damage.
Key points
Iron-containing lesions were suggested as a biomarker for tissue damage, a more aggressive disease course, and worse clinical outcome, but related metabolic alterations are poorly understood
Our MRSI results confirm a higher extent of tissue damage within paramagnetic rim lesions. 46% of newly emerging lesions showed an iron accumulation, correlating with an altered metabolic behavior compared to non-iron lesions
Only 48% of iron-containing lesions have a distinct rim-shaped iron accumulation, although most studies focus on these paramagnetic rim lesions. We showed highly different metabolic profiles in different iron accumulation types, highlighting the need for distinct classification of iron accumulation
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Austrian Science Fund (KLI 718, P 30701, P 34198)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of the Medical University of Vienna gave ethical approval for this work. The approval number is EK 154/2009.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Institutional address: High Field MR Centre, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Lazarettgasse 14, A-1090 Vienna, Austria
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Abbreviations
- EDSS
- Expanded Disability Status Scale
- mIns
- myo-inositol
- tNAA
- total N-acetyl aspartate
- FID-MRSI
- free-induction decay magnetic resonance spectroscopic imaging
- MS
- multiple sclerosis
- NAWM
- normal-appearing white matter
- SWI
- Susceptibility Weighted Imaging
- tCr
- total creatine
- tCho
- total choline